The Obsidio Conformable Embolic recall related to an increased risk for bowel ischemia is the most serious kind, the FDA said on Wednesday, citing two deaths associated with the issue. An ...
On Wednesday, Boston Scientific Corporation (NYSE:BSX) said it recalled Obsidio Embolic by issuing a correction. The FDA has identified this as a Class I recall, the most severe type of recall. An ...
Boston Scientific’s Obsidio Conformable Embolic recall was recently hit with FDA’s Class I classification. The recall is categorized as a correction, not a product removal and comes after the company ...
The FDA recently announced critical recalls on several widely used medical devices, including Life2000 ventilators, Medtronic’s MiniMed insulin pumps and Boston Scientific’s Obsidio conformable ...
Boston Scientific (NYSE:BSX) has issued a corrective recall for its embolization agent Obsidio, warning that the product should not be administered using the aliquot technique. The FDA has classified ...
Boston Scientific announced on August 15, 2022, that it acquired Obsidio, Inc. for an undisclosed fee. Obsidio has technology called the Gel Embolic Material (GEM™), which is used in minimally ...
Medical technology manufacturing company Boston Scientific has acquired Obsidio, a company that makes technology used in the embolization of blood vessels in the peripheral vasculature. Embolization ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results